Newman Robert D, Parise Monica E, Barber Ann M, Steketee Richard W
Malaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
Ann Intern Med. 2004 Oct 5;141(7):547-55. doi: 10.7326/0003-4819-141-7-200410050-00012.
Nearly 1500 malaria cases occur each year in the United States; approximately 60% are among U.S. travelers. Despite the availability of sophisticated medical care, malaria-related deaths continue to occur. The authors reviewed all 185 fatal cases between 1963 and 2001 that were reported to the National Malaria Surveillance System: 123 (66.5%) occurred among U.S. travelers, and of these, 114 (92.7%) were attributed to Plasmodium falciparum. Failure to take or adhere to recommended chemoprophylaxis, to promptly seek medical care for post-travel illness, and to promptly diagnose and treat suspected malaria all contributed to fatal outcomes. Health care providers need to take a travel history, obtain a blood film for suspected malaria, and use the 24-hour malaria management advice available through the Centers for Disease Control and Prevention (CDC) Malaria Hotline (770-488-7788) or the CDC Malaria Web site (http://www.cdc.gov/Malaria). Hospitals must maintain intravenous quinidine gluconate on formulary because it is the only drug available to treat severe malaria in the United States.
美国每年有近1500例疟疾病例;其中约60%发生在美国旅行者中。尽管有先进的医疗服务,但与疟疾相关的死亡仍在继续发生。作者回顾了1963年至2001年期间向国家疟疾监测系统报告的所有185例死亡病例:123例(66.5%)发生在美国旅行者中,其中114例(92.7%)归因于恶性疟原虫。未采取或未坚持推荐的化学预防措施、未及时就医治疗旅行后疾病以及未及时诊断和治疗疑似疟疾均导致了致命后果。医疗服务提供者需要了解旅行史,为疑似疟疾患者采集血片,并利用通过疾病控制与预防中心(CDC)疟疾热线(770-488-7788)或CDC疟疾网站(http://www.cdc.gov/Malaria)提供的24小时疟疾管理建议。医院必须将葡萄糖酸奎尼丁列入处方集,因为它是美国治疗重症疟疾的唯一可用药物。